BLAU3 - Blau Farmacêutica • Financials

Blau Farmaceutica is a multinational pharmaceutical company, a pioneer in biotechnology in Brazil and a strong institutional player. Its business model focuses on five specialties: oncology, hematology, infectious diseases, anesthesiology, and specialties. The company has a portfolio of highly complex drugs, including biologics, oncology, and antibiotics. Blau is present in several Latin American countries, such as Argentina, Colombia, Peru and Uruguay, and also in the United States. The hospital segment accounts for most of its net revenue.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	EBITDA Mrg	D&A	EBIT	Net Int Inc	Taxes	Net Inc DO	Net Inc	Net Mrg	Equity	ROE	Cash&Inv	Debt	ND/EBITDA	OCF	Capex	FCF	Free	Dividend	Payout	DY
12/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
12/2023	1,373	368	27%	-39	329	5	-87	0	247	18%	1,995	12%	407	609	0.55	221	-264	154	-44	66	27%	2.2%
12/2024	1,754	381	22%	-52	329	-37	-78	0	214	12%	2,151	10%	493	559	0.17	507	-284	-191	223	56	26%	2.4%
12/2025	1,702	424	25%	-69	354	34	-92	0	297	17%	2,256	13%	615	599	-	291	-419	-120	-128	82	28%	6.8%
06/26 TTM	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

To see all financials—including updated, you must be Premium.